Intra-amniotic ER004 as a prenatal treatment of X-linked hypohidrotic ectodermal dysplasia (XLHED)

Research unit

INNOSUISSE

Project number

120.370 IP-LS

Project title

Intra-amniotic ER004 as a prenatal treatment of X-linked hypohidrotic ectodermal dysplasia (XLHED)

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Human medicine
Abstract (English)	ER004 is the first therapy specifically addressing X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disorder caused by the lack of a functional ectodysplasin A1 (EDA1) protein. Intra-amniotic treatment with ER004 has the potential to switch off symptoms throughout patients? lives.